Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven E Bellan

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Plos One|January 7, 2017
Correction: Impact of Age and Sex on CD4+ Cell Count Trajectories following Treatment Initiation: An Analysis of the Tanzanian HIV Treatment DatabaseArianna R Means, Kathryn A Risher, Eva L Ujeneza, et al.
American Journal of Epidemiology|May 19, 2016
Reevaluating Cumulative HIV-1 Viral Load as a Prognostic Predictor: Predicting Opportunistic Infection Incidence and Mortality in a Ugandan CohortJoseph B Sempa, Jonathan Dushoff, Michael J Daniels, et al.
BMC Infectious Diseases|May 5, 2017
Assessing real-time Zika risk in the United StatesLauren A Castro, Spencer J Fox, Xi Chen, et al.
The Lancet. Infectious Diseases|April 19, 2015
Statistical power and validity of Ebola vaccine trials in Sierra Leone: a simulation study of trial design and analysisSteven E Bellan, Juliet R C Pulliam, Carl A B Pearson, et al.
Vaccine|June 28, 2019
An online decision tree for vaccine efficacy trial design during infectious disease epidemics: The InterVax-ToolSteven E Bellan, Rosalind M Eggo, Pierre-Stéphane Gsell, et al.
BMC Medicine|December 31, 2017
Simulations for designing and interpreting intervention trials in infectious diseasesM Elizabeth Halloran, Kari Auranen, Sarah Baird, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Plos One|January 7, 2017
Correction: Impact of Age and Sex on CD4+ Cell Count Trajectories following Treatment Initiation: An Analysis of the Tanzanian HIV Treatment DatabaseArianna R Means, Kathryn A Risher, Eva L Ujeneza, et al.
American Journal of Epidemiology|May 19, 2016
Reevaluating Cumulative HIV-1 Viral Load as a Prognostic Predictor: Predicting Opportunistic Infection Incidence and Mortality in a Ugandan CohortJoseph B Sempa, Jonathan Dushoff, Michael J Daniels, et al.
BMC Infectious Diseases|May 5, 2017
Assessing real-time Zika risk in the United StatesLauren A Castro, Spencer J Fox, Xi Chen, et al.
The Lancet. Infectious Diseases|April 19, 2015
Statistical power and validity of Ebola vaccine trials in Sierra Leone: a simulation study of trial design and analysisSteven E Bellan, Juliet R C Pulliam, Carl A B Pearson, et al.
Vaccine|June 28, 2019
An online decision tree for vaccine efficacy trial design during infectious disease epidemics: The InterVax-ToolSteven E Bellan, Rosalind M Eggo, Pierre-Stéphane Gsell, et al.
BMC Medicine|December 31, 2017
Simulations for designing and interpreting intervention trials in infectious diseasesM Elizabeth Halloran, Kari Auranen, Sarah Baird, et al.
Pageof 2